1. Halblander, Fabian N, Meng, Fanju W, Murphy, Patrick J. 2023. Anp32e protects against accumulation of H2A.Z at Sox motif containing promoters during zebrafish gastrulation. In bioRxiv : the preprint server for biology, , . doi:10.1101/2023.12.18.572196. https://pubmed.ncbi.nlm.nih.gov/38187710/
2. Xiong, Zhenchong, Ye, Liping, Zhenyu, He, Yuan, Zhongyu, Wang, Xi. 2018. ANP32E induces tumorigenesis of triple-negative breast cancer cells by upregulating E2F1. In Molecular oncology, 12, 896-912. doi:10.1002/1878-0261.12202. https://pubmed.ncbi.nlm.nih.gov/29633513/
3. Wong, Peiyan, Leo, Vonny I, Low, Meijun, Zhang, Xiaodong, Reilly, Patrick T. 2013. Targeted ANP32E mutant mice do not demonstrate obvious movement defects. In PloS one, 8, e63815. doi:10.1371/journal.pone.0063815. https://pubmed.ncbi.nlm.nih.gov/23675506/
4. Sun, Li-Ying, Ke, Shao-Bo, Li, Bo-Xin, Liu, Yi, Chen, Yong-Shun. 2024. ANP32E promotes esophageal cancer progression and paclitaxel resistance via P53/SLC7A11 axis-regulated ferroptosis. In International immunopharmacology, 144, 113436. doi:10.1016/j.intimp.2024.113436. https://pubmed.ncbi.nlm.nih.gov/39566382/